These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1810735)

  • 1. Usefulness of semi-quantitative cultures in the diagnosis of Clostridium difficile associated disease.
    Poirier L; Lamothe F; Vincelette J; Bourgault AM
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):770-2. PubMed ID: 1810735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic pitfalls in Clostridium difficile infection.
    Planche T; Wilcox MH
    Infect Dis Clin North Am; 2015 Mar; 29(1):63-82. PubMed ID: 25595842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
    René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
    Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of Clostridium difficile cytotoxin assay.
    Sanderson PJ; Alshafi KM
    J Hosp Infect; 1995 Jul; 30(3):236-7. PubMed ID: 8522782
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the laboratory in investigations of Clostridium difficile diarrhea.
    Brazier JS
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S228-33. PubMed ID: 8324124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Clostridium difficile toxins A (enterotoxin) and B (cytotoxin) in clinical specimens. Evaluation of a latex agglutination test.
    Peterson LR; Holter JJ; Shanholtzer CJ; Garrett CR; Gerding DN
    Am J Clin Pathol; 1986 Aug; 86(2):208-11. PubMed ID: 3739972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of
    Senok AC; Aldosari KM; Alowaisheq RA; Abid OA; Alsuhaibani KA; Khan MA; Somily AM
    Saudi J Gastroenterol; 2017; 23(4):259-262. PubMed ID: 28721981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium difficile cytotoxin in HEp-2 and CHO cell lines.
    Murray PR; Weber CJ
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):331-3. PubMed ID: 6667607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the two-step and the three-step algorithms for the detection of toxigenic Clostridium difficile.
    Qutub MO; AlBaz N; Hawken P; Anoos A
    Indian J Med Microbiol; 2011; 29(3):293-6. PubMed ID: 21860113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the ToxA test with cytotoxicity assay and culture for the detection of Clostridium difficile-associated diarrhoea disease.
    Schué V; Green GA; Monteil H
    J Med Microbiol; 1994 Nov; 41(5):316-8. PubMed ID: 7966202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.
    Wolfhagen MJ; Meijer K; Fluit AC; Torensma R; Bruinsma RA; Fleer A; Verhoef J
    Gut; 1994 Nov; 35(11):1608-12. PubMed ID: 7828982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.
    Terveer EM; Crobach MJ; Sanders IM; Vos MC; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2017 Feb; 55(2):403-411. PubMed ID: 27852676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the clinical microbiology laboratory in the management of Clostridium difficile-associated diarrhea.
    Peterson LR; Kelly PJ
    Infect Dis Clin North Am; 1993 Jun; 7(2):277-93. PubMed ID: 8345170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of CIE for the detection of Clostridium difficile toxin in stool filtrates: laboratory and clinical correlation.
    Kurzynski TA; Cembrowski GS; Kimball JL
    Am J Clin Pathol; 1983 Mar; 79(3):370-4. PubMed ID: 6829506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Stability of Clostridium difficile Toxins in Clinical Specimens.
    Schora DM; Peterson LR; Usacheva EA
    Infect Control Hosp Epidemiol; 2018 Apr; 39(4):434-438. PubMed ID: 29457584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.